Advertisement

Topics

Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

16:15 EDT 10 May 2019 | Reuters

Eli Lilly and Co has pulled ahead in a three-way race with Amgen Inc and Teva Pharmaceutical Industries Ltd in attracting new patients to a new class of migraine drugs, and seeks to build on that advantage by stressing that its therapy can completely...

Original Article: Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

NEXT ARTICLE

More From BioPortfolio on "Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...